Catalyst Capital Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Catalyst Capital Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-208	Closed	-$7K	–	431
2019 Q3	$7K	Hold	208	–	–	﹤0.01%	376
2019 Q2	$10K	Buy	+208	New	+$8.85K	﹤0.01%	319

Other funds holding SILK

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Catalyst Capital Advisors's SILK Position: Q4 2019 in Review

Catalyst Capital Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2019, closing a stake of 208 shares — an estimated $7K sold.

Catalyst Capital Advisors first reported a position in SILK in Q2 2019 and held it in 2 quarters. The position peaked at $10K in Q2 2019. 130 funds tracked by Wall St. Rank hold SILK as of Q4 2019.

Catalyst Capital Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Catalyst Capital Advisors sold 208 Silk Road Medical, Inc. Common Stock shares in Q4 2019, an estimated $7K.
Catalyst Capital Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Catalyst Capital Advisors's Silk Road Medical, Inc. Common Stock position peaked at $10K in Q2 2019.
130 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2019.

Based on Catalyst Capital Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.